Postdoctoral Researcher - DNA Damage Signalling and Repair

Applications are invited for a postdoctoral research position within the Genome Stability and Tumourigenesis Group led by Professor Madalena Tarsounas. The primary goal of the Genome Stability and Tumourigenesis Group is to investigate how tumour cells lacking BRCA1 or BRCA2 tumour suppressors develop tolerance to endogenous replication stress and how this, in turn, sustains cell proliferation and tumour growth.
We are looking for a highly motivated postdoctoral researcher interested in investigating how defects in replication and checkpoint signalling lead to chromosome missegregation during mitosis in cells lacking BRCA2. The successful candidate will carry out research using mass spectrometry as a discovery tool, combined with hypothesis-driven cell biological and biochemical approaches to identify activities other than MUS81 that promote progression of BRCA2-deficient cells through mitosis and prevent lethal loss of chromosome integrity in cancer cells carrying BRCA2 mutations.
You will hold, or be working towards, a PhD in cell biology, molecular biology, genetics or biochemistry (or related area of research) and will be highly motivated and committed to achieve clear career goals. A proven high-level of technical competence in standard cell and molecular biology techniques is essential. You will also have strong research track record in DNA damage signalling/repair and a good publication record with a minimum of one first-author publication in a peer-review journal.
This is a full-time post and is offered for a fixed-term of 3 years in the first instance with the possibility of extension.
All applicants must complete a short online application form and upload a CV with publication list, a supporting statement and a reprint of their best article.
To apply for this role, please click on the ‘Apply Now’ button in the link below.
The closing date for applications has been extended until 12.00 noon on 30 August 2017.
Please note that the University of Oxford's retirement policy is changing. With effect from 1 October 2017, all employees at Grade 8 and above will have a retirement age of 68, and all employees at Grades 6 and 7 will no longer have a set retirement age. Further details are available here:

Closing Date: 
Wednesday, August 30, 2017 - 12:00
CRUK/MRC Oxford Institute for Radiation and Oncology
About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.